D. Turci
Impact in
- Oncology top 5%
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
- Cancer Immunotherapy and Biomarkers
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Oncology 38
- Colorectal Cancer Treatments and Studies 16
- Cancer Immunotherapy and Biomarkers 14
- Cancer Treatment and Pharmacology 12
-
- Hepatocellular Carcinoma Treatment and Prognosis 6
- Co-authors
- M. MarangoloOriana NanniGiovanni Luca FrassinetiPetros GiovanisClaudio DazziAnna CarielloD. AmadoriDavide Tassinari
- Journals
- Annals of Oncology (11 papers)Journal of Thoracic Oncology (5 papers)Journal of Clinical Oncology (5 papers)British Journal of Cancer (2 papers)Bone Marrow Transplantation (2 papers)
- Partner nations
- ItalyUnited StatesGermany
In The Last Decade
D. Turci
43 papers receiving 616 citations
Peers
Comparison fields: 5 of 62
- Oncology 492
- Hepatology 120
- Otorhinolaryngology 56
- Pulmonary and Respiratory Medicine 250
- Pathology and Forensic Medicine 81
Countries citing papers authored by D. Turci
This map shows the geographic impact of D. Turci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Turci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Turci more than expected).
Fields of papers citing papers by D. Turci
This network shows the impact of papers produced by D. Turci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Turci. The network helps show where D. Turci may publish in the future.
Co-authorship network
The 25 scholars most cited alongside D. Turci, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 6 | |
| 2 | 2017 | 1 | |
| 3 | 2017 | 2 | |
| 4 | 2017 | 2 | |
| 5 | 2017 | 4 | |
| 6 | 2017 | 5 | |
| 7 | 2017 | 9 | |
| 8 | 2016 | 5 | |
| 9 | 2015 | 121 | |
| 10 | 2010 | 72 | |
| 11 | 2008 | 4 | |
| 12 | 2006 | 28 | |
| 13 | 2003 | 54 | |
| 14 | 2003 | 6 | |
| 15 | 2002 | 36 | |
| 16 | 2001 | 12 | |
| 17 | 2000 | 15 | |
| 18 | 2000 | 32 | |
| 19 | 1999 | 14 | |
| 20 | Hepatic arterial infusion (HAI) of high dose chemotherapy plus caval chemofiltration vs HAI of prolonged low doses in patients with liver matastases from colorectal carcinoma: Result of a prospective randomized trial. | 1994 | 3 |
About D. Turci
D. Turci is a scholar working on Oncology, Hepatology, Pulmonary and Respiratory Medicine, Cancer Research and Otorhinolaryngology, having authored 43 papers that have together received 637 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (16 papers), Cancer Immunotherapy and Biomarkers (14 papers), Cancer Treatment and Pharmacology (12 papers), Lung Cancer Treatments and Mutations (8 papers), Hepatocellular Carcinoma Treatment and Prognosis (6 papers), Gastric Cancer Management and Outcomes (6 papers), Economic and Financial Impacts of Cancer (5 papers) and Genetic factors in colorectal cancer (4 papers). The work is most often cited by research in Oncology (492 citations), Hepatology (120 citations), Otorhinolaryngology (56 citations), Pulmonary and Respiratory Medicine (250 citations) and Pathology and Forensic Medicine (81 citations). D. Turci has collaborated with scholars based in Italy, United States and Germany. Frequent co-authors include M. Marangolo, Oriana Nanni, Giovanni Luca Frassineti, Petros Giovanis, Claudio Dazzi, Anna Cariello, D. Amadori, Davide Tassinari, A. Tienghi and Maurizio Leoni. Their work appears in journals such as Annals of Oncology, Journal of Thoracic Oncology, Journal of Clinical Oncology, British Journal of Cancer and Bone Marrow Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.